ReWalk Robotics (LFWD) Competitors $1.41 -0.06 (-4.08%) As of 04/30/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LFWD vs. VANI, GUTS, HYPR, SPAI, APT, OM, MODD, ECOR, BDMD, and TELAShould you be buying ReWalk Robotics stock or one of its competitors? The main competitors of ReWalk Robotics include Vivani Medical (VANI), Fractyl Health (GUTS), Hyperfine (HYPR), Safe Pro Group Inc. Common Stock (SPAI), Alpha Pro Tech (APT), Outset Medical (OM), Modular Medical (MODD), electroCore (ECOR), Baird Medical Investment (BDMD), and TELA Bio (TELA). These companies are all part of the "medical equipment" industry. ReWalk Robotics vs. Vivani Medical Fractyl Health Hyperfine Safe Pro Group Inc. Common Stock Alpha Pro Tech Outset Medical Modular Medical electroCore Baird Medical Investment TELA Bio Vivani Medical (NASDAQ:VANI) and ReWalk Robotics (NASDAQ:LFWD) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, earnings, profitability, analyst recommendations, risk, media sentiment, institutional ownership, community ranking and valuation. Do analysts rate VANI or LFWD? Vivani Medical presently has a consensus price target of $4.00, indicating a potential upside of 288.35%. ReWalk Robotics has a consensus price target of $9.00, indicating a potential upside of 538.30%. Given ReWalk Robotics' higher probable upside, analysts clearly believe ReWalk Robotics is more favorable than Vivani Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vivani Medical 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00ReWalk Robotics 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has preferable earnings & valuation, VANI or LFWD? ReWalk Robotics has higher revenue and earnings than Vivani Medical. Vivani Medical is trading at a lower price-to-earnings ratio than ReWalk Robotics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVivani MedicalN/AN/A-$25.65M-$0.44-2.34ReWalk Robotics$25.66M0.58-$22.13M-$3.31-0.43 Is VANI or LFWD more profitable? Vivani Medical has a net margin of 0.00% compared to ReWalk Robotics' net margin of -77.21%. ReWalk Robotics' return on equity of -43.02% beat Vivani Medical's return on equity.Company Net Margins Return on Equity Return on Assets Vivani MedicalN/A -102.42% -49.21% ReWalk Robotics -77.21%-43.02%-31.53% Does the MarketBeat Community prefer VANI or LFWD? ReWalk Robotics received 5 more outperform votes than Vivani Medical when rated by MarketBeat users. CompanyUnderperformOutperformVivani MedicalOutperform Votes6100.00% Underperform VotesNo VotesReWalk RoboticsOutperform Votes11100.00% Underperform VotesNo Votes Which has more volatility and risk, VANI or LFWD? Vivani Medical has a beta of 2.76, meaning that its share price is 176% more volatile than the S&P 500. Comparatively, ReWalk Robotics has a beta of 1.51, meaning that its share price is 51% more volatile than the S&P 500. Do institutionals and insiders believe in VANI or LFWD? 6.8% of Vivani Medical shares are held by institutional investors. Comparatively, 26.8% of ReWalk Robotics shares are held by institutional investors. 44.3% of Vivani Medical shares are held by company insiders. Comparatively, 2.5% of ReWalk Robotics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Does the media refer more to VANI or LFWD? In the previous week, ReWalk Robotics had 2 more articles in the media than Vivani Medical. MarketBeat recorded 4 mentions for ReWalk Robotics and 2 mentions for Vivani Medical. Vivani Medical's average media sentiment score of 1.30 beat ReWalk Robotics' score of 0.47 indicating that Vivani Medical is being referred to more favorably in the media. Company Overall Sentiment Vivani Medical Positive ReWalk Robotics Neutral SummaryReWalk Robotics beats Vivani Medical on 10 of the 15 factors compared between the two stocks. Get ReWalk Robotics News Delivered to You Automatically Sign up to receive the latest news and ratings for LFWD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LFWD vs. The Competition Export to ExcelMetricReWalk RoboticsSurgical appliances & supplies IndustryComputer SectorNASDAQ ExchangeMarket Cap$14.99M$9.15B$23.05B$7.83BDividend YieldN/A1.64%2.97%4.22%P/E Ratio-0.5719.2742.1318.48Price / Sales0.5871.132,076.99103.59Price / CashN/A19.6734.7234.62Price / Book0.264.956.134.25Net Income-$22.13M$284.66M$738.82M$248.23M7 Day Performance-4.08%0.01%1.30%0.89%1 Month Performance-20.34%1.87%1.64%3.53%1 Year Performance-70.32%-17.14%52,744.82%5.08% ReWalk Robotics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LFWDReWalk Robotics2.541 of 5 stars$1.41-4.1%$9.00+538.3%-70.3%$14.99M$25.66M-0.5760VANIVivani Medical3.2864 of 5 stars$1.05flat$4.00+281.0%-36.4%$62.20MN/A-2.3320Positive NewsGUTSFractyl Health1.5914 of 5 stars$1.20-4.8%$11.00+816.7%-81.2%$58.70M$93,000.00-0.10102HYPRHyperfine3.5749 of 5 stars$0.74-1.6%$1.33+78.5%-10.5%$57.98M$12.89M-1.31190Short Interest ↓Positive NewsSPAISafe Pro Group Inc. Common StockN/A$3.39+3.7%N/AN/A$51.43M$2.17M0.0011Gap UpAPTAlpha Pro TechN/A$4.39-1.8%N/A-27.2%$47.73M$57.84M11.86120Analyst ForecastGap DownOMOutset Medical0.9482 of 5 stars$11.61+0.3%$35.00+201.5%-72.0%$41.74M$113.69M-4.68520Upcoming EarningsMODDModular Medical1.9571 of 5 stars$1.02+9.7%N/A-31.6%$41.48MN/A-1.9220Short Interest ↓Negative NewsECORelectroCore2.6083 of 5 stars$7.38-2.5%$25.50+245.5%+20.3%$40.71M$25.18M-4.0350Upcoming EarningsPositive NewsBDMDBaird Medical InvestmentN/A$5.95+4.2%N/AN/A$39.18M$33.05M0.00N/ATELATELA Bio2.9759 of 5 stars$0.960.0%$7.25+655.8%-78.5%$37.95M$69.30M-0.57120Short Interest ↓Positive NewsGap Up Related Companies and Tools Related Companies Vivani Medical Competitors Fractyl Health Competitors Hyperfine Competitors Safe Pro Group Inc. Common Stock Competitors Alpha Pro Tech Competitors Outset Medical Competitors Modular Medical Competitors electroCore Competitors Baird Medical Investment Competitors TELA Bio Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LFWD) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredThey rigged the gameThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredIf you missed your chance with Tesla...Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ReWalk Robotics Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share ReWalk Robotics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.